VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
GEHCGE HealthCare Technologies Inc.
$61.59$28.0B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksGEHCPrice Target
GEHC logo

GE HealthCare Technologies Inc. (GEHC) Price Target Analysis

Updated Jun 18, 2026
Analyst Rating: Buy
Based on 18 analysts

31.7% Below Target

GEHC trades 31.7% below Wall Street's consensus target of $81.10.

Current Price$61.59
Average Target$81.10
Target
Current
Low$65.00
Median$82.50
High$91.00

Analyst Target Range

Forward P/E12.6x
(Value)
PEG Ratio20.13
(Expensive)
Implied Growth+48.2%
(High Growth)
Analyst Spread32.1%
(Moderate)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$61.59
Consensus$81.10
High$91.00
Low$65.00

Consensus Scenario Assumptions

The base valuation assumes GEHC achieves its forward estimates and maintains a stable P/E multiple of 12.6x. This scenario reflects the blended consensus of 18 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 18 published analyst recommendations for GEHC

44% hold / mixed conviction
+28
BearishBullish
Weighted analyst sentiment score based on 18 ratings
ConsensusBuy
Coverage18 Analysts
Net Score+28
Bull / Bear56% / 0%
Strong Buy00%
Buy1056%
Hold844%
Sell00%
Strong Sell00%
Strong Buy
00%
Buy
1056%
Hold
844%
Sell
00%
Strong Sell
00%
Recommendation Mix56% Buy · 44% Hold · 0% Sell
Buy (10)Hold (8)Sell (0)

GEHC Price Target Analysis

Updated June 22, 2026

As of June 22, 2026, GE HealthCare Technologies Inc. (GEHC) has a Wall Street consensus price target of $81.10, based on estimates from 18 covering analysts. With the stock currently trading at $61.59, this represents a potential upside of +31.7%. The company has a market capitalization of $28.02B.

Analyst price targets range from a low of $65.00 to a high of $91.00, representing a 32% spread in expectations. The median target of $82.50 aligns closely with the consensus average.

The current analyst consensus rating is Buy, with 10 analysts rating the stock as a Buy or Strong Buy,8 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.

From a valuation perspective, GEHC trades at a trailing P/E of 13.5x and forward P/E of 12.6x. The forward PEG ratio of 20.13 reflects a premium valuation. Analysts expect EPS to grow +48.2% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $67.34, with bear and bull scenarios of $42.42 and $88.72 respectively. Model confidence stands at 54/100, reflecting moderate uncertainty in projections.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+27.6%
Industry Consensus
Avg Forward P/E
19.4x
(Fair)
Peers with Coverage
9 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
SYK logo
SYKStryker Corporation
$117.9B$307.80$387.46
+25.9%
Buy20.5x51
BSX logo
BSXBoston Scientific Corporation
$67.3B$45.29$82.90
+83.0%
Buy13.5x44
EW logo
EWEdwards Lifesciences Corporation
$50.4B$87.36$96.55
+10.5%
Buy29.0x48
PHG logo
PHGKoninklijke Philips N.V.
$25.5B$26.78——Hold17.1x22
HOLX logo
HOLXHologic, Inc.
$17.0B$76.01$78.69
+3.5%
Hold17.2x42
MDT logo
MDTMedtronic plc
$101.9B$79.34$95.80
+20.7%
Buy13.3x51
ABT logo
ABTAbbott Laboratories
$153.7B$88.38$127.46
+44.2%
Buy16.1x41
BAX logo
BAXBaxter International Inc.
$10.3B$19.89$20.71
+4.1%
Hold10.4x36
ISRG logo
ISRGIntuitive Surgical, Inc.
$144.5B$406.78$597.78
+47.0%
Buy38.9x55
NVST logo
NVSTEnvista Holdings Corp
$4.2B$25.91$28.33
+9.3%
Hold18.1x19

GEHC — Frequently Asked Questions

Quick answers to the most common questions about buying GEHC stock.

What is the GEHC stock price target for 2026?

The consensus Wall Street price target for GEHC is $81.1, representing 31.7% upside from the current price of $61.59. With 18 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

Is GEHC a buy, sell, or hold?

GEHC has a consensus rating of "Buy" based on 18 Wall Street analysts. The rating breakdown is predominantly bullish, with 10 Buy/Strong Buy ratings. The consensus 12-month price target of $81.1 implies 31.7% upside from current levels.

Is GEHC stock overvalued or undervalued?

With a forward P/E of 12.6222x, GEHC trades at a relatively low valuation. The consensus target of $81.1 implies 31.7% appreciation, suggesting meaningful undervaluation.

How high can GEHC stock go?

The most bullish Wall Street analyst has a price target of $91 for GEHC, while the most conservative target is $65. The consensus of $81.1 represents the median expectation. Our quantitative valuation model projects a bull case target of $89 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover GEHC stock?

GEHC is well covered by analysts, with 18 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 10 have Buy ratings, 8 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the GEHC stock forecast?

The 12-month GEHC stock forecast based on 18 Wall Street analysts shows a consensus price target of $81.1, with estimates ranging from $65 (bear case) to $91 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $67, with bear/bull scenarios of $42/$89.

What is GEHC's fair value based on fundamentals?

Our quantitative valuation model calculates GEHC's fair value at $67 (base case), with a bear case of $42 and bull case of $89. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 54/100.

What is GEHC's forward P/E ratio?

GEHC trades at a forward P/E ratio of 12.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 13.5x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy GEHC stock?

Wall Street analysts are very optimistic on GEHC, with a "Buy" consensus rating and $81.1 price target (31.7% upside). 10 of 18 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do GEHC price targets vary so much?

GEHC analyst price targets range from $65 to $91, a 32% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $81.1 consensus represents the middle ground. Our model's $42-$89 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into GEHC consensus models and risk factors.

View Analysis

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare